BIOMAT Database Logo BIOMAT Database Logo

Liver iron overload and desferrioxamine treatment of porphyria cutanea tarda. 1991

E Rocchi, and M Cassanelli, and A Borghi, and F Paolillo, and M Pradelli, and S Pellizzardi, and A Vezzosi, and E Gallo, and M Baccarani Contri, and E Ventura
Chair of Terapia Medica Sistematica, University of Modena, Italy.

The aim of this paper is to evaluate invasive and non-invasive indices of iron store and compare the effectiveness of different ferrodepletive protocols in 150 patients with porphyria cutanea tarda (PCT). Iron removal was performed either by intensive phlebotomy (22 cases) or slow subcutaneous and high intravenous doses of desferrioxamine (18 and 5 cases, respectively), and several laboratory parameters were studied; among these, oligo-elements and urinary porphyrins (detected by HPLC) were taken into account before and after the treatments. Serum iron, transferrin saturation, ferritin (RIA) and nuclear magnetic resonance results were compared with invasive findings in order to detect the metal deposition in liver tissue (atomic absorption concentration, optic or electron-microscopic detection). Liver iron overload was observed in 95% of cases. Full normalization of the disease took place by all the treatments, even if it required slightly more time in the phlebotomy group. We may conclude that ferrodepletive treatments are highly effective in PCT and, considering the fact that siderosis and liver damage always accompany the disease, these treatments are proposed as first choice in such cases.

UI MeSH Term Description Entries
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D011164 Porphyrias A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues. Porphyria,Porphyrin Disorder,Disorder, Porphyrin,Disorders, Porphyrin,Porphyrin Disorders
D001815 Bloodletting Puncture of a vein to draw blood for therapeutic purposes. Bloodletting therapy has been used in Talmudic and Indian medicine since the medieval time, and was still practiced widely in the 18th and 19th centuries. Its modern counterpart is PHLEBOTOMY.
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003676 Deferoxamine Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. Desferrioxamine,Deferoxamine B,Deferoxamine Mesilate,Deferoxamine Mesylate,Deferoxamine Methanesulfonate,Deferoximine,Deferrioxamine B,Desferal,Desferioximine,Desferrioxamine B,Desferrioxamine B Mesylate,Desferroxamine,Mesilate, Deferoxamine,Mesylate, Deferoxamine,Mesylate, Desferrioxamine B,Methanesulfonate, Deferoxamine
D005293 Ferritins Iron-containing proteins that are widely distributed in animals, plants, and microorganisms. Their major function is to store IRON in a nontoxic bioavailable form. Each ferritin molecule consists of ferric iron in a hollow protein shell (APOFERRITINS) made of 24 subunits of various sequences depending on the species and tissue types. Basic Isoferritin,Ferritin,Isoferritin,Isoferritin, Basic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E Rocchi, and M Cassanelli, and A Borghi, and F Paolillo, and M Pradelli, and S Pellizzardi, and A Vezzosi, and E Gallo, and M Baccarani Contri, and E Ventura
Iron overload in porphyria cutanea tarda.
March 1999, Haematologica,
E Rocchi, and M Cassanelli, and A Borghi, and F Paolillo, and M Pradelli, and S Pellizzardi, and A Vezzosi, and E Gallo, and M Baccarani Contri, and E Ventura
Iron overload in porphyria cutanea tarda.
November 2000, The British journal of dermatology,
E Rocchi, and M Cassanelli, and A Borghi, and F Paolillo, and M Pradelli, and S Pellizzardi, and A Vezzosi, and E Gallo, and M Baccarani Contri, and E Ventura
Phlebotomy and iron-overload in porphyria cutanea tarda.
June 1969, Lancet (London, England),
E Rocchi, and M Cassanelli, and A Borghi, and F Paolillo, and M Pradelli, and S Pellizzardi, and A Vezzosi, and E Gallo, and M Baccarani Contri, and E Ventura
[Treatment of porphyria cutanea tarda with desferrioxamine (Desferal)].
December 1967, Minerva dermatologica,
E Rocchi, and M Cassanelli, and A Borghi, and F Paolillo, and M Pradelli, and S Pellizzardi, and A Vezzosi, and E Gallo, and M Baccarani Contri, and E Ventura
Porphyria cutanea tarda and beta-thalassaemia minor with iron overload.
October 1980, British medical journal,
E Rocchi, and M Cassanelli, and A Borghi, and F Paolillo, and M Pradelli, and S Pellizzardi, and A Vezzosi, and E Gallo, and M Baccarani Contri, and E Ventura
Porphyria cutanea tarda and beta-thalassaemia minor with iron overload.
September 1980, British medical journal,
E Rocchi, and M Cassanelli, and A Borghi, and F Paolillo, and M Pradelli, and S Pellizzardi, and A Vezzosi, and E Gallo, and M Baccarani Contri, and E Ventura
Iron and porphyria cutanea tarda.
February 1997, Cellular and molecular biology (Noisy-le-Grand, France),
E Rocchi, and M Cassanelli, and A Borghi, and F Paolillo, and M Pradelli, and S Pellizzardi, and A Vezzosi, and E Gallo, and M Baccarani Contri, and E Ventura
Mutations in the hemochromatosis gene, porphyria cutanea tarda, and iron overload.
January 1998, Hepatology (Baltimore, Md.),
E Rocchi, and M Cassanelli, and A Borghi, and F Paolillo, and M Pradelli, and S Pellizzardi, and A Vezzosi, and E Gallo, and M Baccarani Contri, and E Ventura
Rare cases of porphyria cutanea tarda associated with additional iron overload.
February 1982, Dermatologica,
E Rocchi, and M Cassanelli, and A Borghi, and F Paolillo, and M Pradelli, and S Pellizzardi, and A Vezzosi, and E Gallo, and M Baccarani Contri, and E Ventura
Ferrous iron and porphyria cutanea tarda.
June 1977, Archives of dermatology,
Copied contents to your clipboard!